Refine by
Precision Medicines Articles & Analysis: This-Year
2 news found
Hemostemix Inc. (“Hemostemix” or the “Company”) (TSXV: HEM, OTCQB: HMTXF; FSE:2VF0), the leading autologous (patient’s own) stem cell therapy company treating no-option patients in Florida suffering in pain from Chronic Limb Threatening Ischemia, Peripheral Arterial Disease and Angina, is pleased to announce its webinar topic for Thursday, August 21, 2025. Croom ...
Additionally, exosome-loaded protein-based therapy is opening new doors for regenerative medicine, while limb occlusion research is enhancing vascular treatments. ...